161 related articles for article (PubMed ID: 29861268)
1. Real-time Doppler ultrasound to identify vessels and guide needle placement for gynecologic interstitial brachytherapy.
Sethi R; Kuo YC; Edraki B; Lerner D; Paik D; Bice W
Brachytherapy; 2018; 17(5):742-746. PubMed ID: 29861268
[TBL] [Abstract][Full Text] [Related]
2. Two-year results of transabdominal ultrasound-guided brachytherapy for cervical cancer.
Tharavichitkul E; Tippanya D; Jayavasti R; Chakrabandhu S; Klunklin P; Onchan W; Wanwilairat S; Galalae RM; Chitapanarux I
Brachytherapy; 2015; 14(2):238-44. PubMed ID: 25483020
[TBL] [Abstract][Full Text] [Related]
3. Interstitial round needles should not be used for cervical cancer patient treated with intracavitary/ interstitial brachytherapy using a Venezia applicator : a case report.
Takagawa Y; Izumi S; Takahashi E; Kita M
BMC Womens Health; 2024 Apr; 24(1):249. PubMed ID: 38637783
[TBL] [Abstract][Full Text] [Related]
4. Three-dimensional transrectal ultrasound guided high-dose-rate prostate brachytherapy: A comparison of needle segmentation accuracy with two-dimensional image guidance.
Hrinivich WT; Hoover DA; Surry K; Edirisinghe C; Montreuil J; D'Souza D; Fenster A; Wong E
Brachytherapy; 2016; 15(2):231-9. PubMed ID: 26832673
[TBL] [Abstract][Full Text] [Related]
5. Clinical use of the Utrecht applicator for combined intracavitary/interstitial brachytherapy treatment in locally advanced cervical cancer.
Nomden CN; de Leeuw AA; Moerland MA; Roesink JM; Tersteeg RJ; Jürgenliemk-Schulz IM
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1424-30. PubMed ID: 21669505
[TBL] [Abstract][Full Text] [Related]
6. Assessment of Parametrial Response by Growth Pattern in Patients With International Federation of Gynecology and Obstetrics Stage IIB and IIIB Cervical Cancer: Analysis of Patients From a Prospective, Multicenter Trial (EMBRACE).
Yoshida K; Jastaniyah N; Sturdza A; Lindegaard J; Segedin B; Mahantshetty U; Rai B; Jürgenliemk-Schulz I; Haie-Meder C; Sasaki R; Pötter R
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):788-96. PubMed ID: 26530747
[TBL] [Abstract][Full Text] [Related]
7. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
Ribeiro I; Janssen H; De Brabandere M; Nulens A; De Bal D; Vergote I; Van Limbergen E
Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510
[TBL] [Abstract][Full Text] [Related]
8. Pulsed-dose-rate brachytherapy for uterine cervix carcinoma: 10 years of experience with 226 patients at a single institution.
Petit A; Floquet A; Lasbareilles O; Stoeckle E; Chemin A; Kind M; Guyon F; Brouste V; Pigneux J; Thomas L
Brachytherapy; 2013; 12(6):542-9. PubMed ID: 23880416
[TBL] [Abstract][Full Text] [Related]
9. Early clinical outcomes of ultrasound-guided CT-planned high-dose-rate interstitial brachytherapy for primary locally advanced cervical cancer.
Mesko S; Swamy U; Park SJ; Borja L; Wang J; Demanes DJ; Kamrava M
Brachytherapy; 2015; 14(5):626-32. PubMed ID: 26024784
[TBL] [Abstract][Full Text] [Related]
10. Computed Tomography-Guided Interstitial Brachytherapy for Locally Advanced Cervical Cancer: Introduction of the Technique and a Comparison of Dosimetry With Conventional Intracavitary Brachytherapy.
Liu ZS; Guo J; Zhao YZ; Lin X; Zhang BY; Zhang C; Wang HY; Yu L; Ren XJ; Wang TJ
Int J Gynecol Cancer; 2017 May; 27(4):768-775. PubMed ID: 28267131
[TBL] [Abstract][Full Text] [Related]
11. Comparison of clinical outcomes achieved with image-guided adaptive brachytherapy for cervix cancer using CT or transabdominal ultrasound.
Tharavichitkul E; Muangwong P; Chakrabandhu S; Klunklin P; Onchan W; Jia-Mahasap B; Nobnop W; Tippanya D; Galalae RM; Chitapanarux I
Brachytherapy; 2021; 20(3):543-549. PubMed ID: 33551272
[TBL] [Abstract][Full Text] [Related]
12. Toward a 3D transrectal ultrasound system for verification of needle placement during high-dose-rate interstitial gynecologic brachytherapy.
Rodgers JR; Surry K; Leung E; D'Souza D; Fenster A
Med Phys; 2017 May; 44(5):1899-1911. PubMed ID: 28295403
[TBL] [Abstract][Full Text] [Related]
13. Optimization of high-dose-rate cervix brachytherapy applicator placement: the benefits of intraoperative ultrasound guidance.
Davidson MT; Yuen J; D'Souza DP; Radwan JS; Hammond JA; Batchelar DL
Brachytherapy; 2008; 7(3):248-53. PubMed ID: 18635025
[TBL] [Abstract][Full Text] [Related]
14. Cervical cancer brachytherapy in Canada: A focus on interstitial brachytherapy utilization.
Taggar AS; Phan T; Traptow L; Banerjee R; Doll CM
Brachytherapy; 2017; 16(1):161-166. PubMed ID: 27914911
[TBL] [Abstract][Full Text] [Related]
15. Clinical feasibility of combined intracavitary/interstitial brachytherapy in locally advanced cervical cancer employing MRI with a tandem/ring applicator in situ and virtual preplanning of the interstitial component.
Fokdal L; Tanderup K; Hokland SB; Røhl L; Pedersen EM; Nielsen SK; Paludan M; Lindegaard JC
Radiother Oncol; 2013 Apr; 107(1):63-8. PubMed ID: 23452917
[TBL] [Abstract][Full Text] [Related]
16. A new technique for performing Syed-Neblett template interstitial implants for gynecologic malignancies using transrectal-ultrasound guidance.
Stock RG; Chan K; Terk M; Dewyngaert JK; Stone NN; Dottino P
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(4):819-25. PubMed ID: 9128957
[TBL] [Abstract][Full Text] [Related]
17. Combined intracavitary and interstitial brachytherapy of cervical cancer using the novel hybrid applicator Venezia: Clinical feasibility and initial results.
Walter F; Maihöfer C; Schüttrumpf L; Well J; Burges A; Ertl-Wagner B; Mahner S; Belka C; Gallwas J; Corradini S
Brachytherapy; 2018; 17(5):775-781. PubMed ID: 29941345
[TBL] [Abstract][Full Text] [Related]
18. Comparison of measurements of the uterus and cervix obtained by magnetic resonance and transabdominal ultrasound imaging to identify the brachytherapy target in patients with cervix cancer.
van Dyk S; Kondalsamy-Chennakesavan S; Schneider M; Bernshaw D; Narayan K
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):860-5. PubMed ID: 24462382
[TBL] [Abstract][Full Text] [Related]
19. Novel use of ViewRay MRI guidance for high-dose-rate brachytherapy in the treatment of cervical cancer.
Ko HC; Huang JY; Miller JR; Das RK; Wallace CR; De Costa AA; Francis DM; Straub MR; Anderson BM; Bradley KA
Brachytherapy; 2018; 17(4):680-688. PubMed ID: 29773331
[TBL] [Abstract][Full Text] [Related]
20. Intermediate dose-volume parameters and the development of late rectal toxicity after MRI-guided brachytherapy for locally advanced cervix cancer.
Ujaimi R; Milosevic M; Fyles A; Beiki-Ardakani A; Carlone M; Jiang H; Lindsay P; Xie J; Gerber R; Croke J; Skliarenko J; Levin W; Han K
Brachytherapy; 2017; 16(5):968-975.e2. PubMed ID: 28757404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
